2020 to 2024 Saw Drop in Flu Vaccine Uptake Among U.S. Adults
By Lori Solomon HealthDay Reporter
FRIDAY, July 18, 2025 -- There was an overall decrease in influenza vaccine uptake among U.S. adults from 2020 to 2024, according to a study published online July 16 in PLOS Global Public Health.
Hannah Melchinger, from the Peter O'Donnell Jr. School of Public Health at UT Southwestern Medical Center in Dallas, and colleagues conducted two distinct, cross-sectional surveys assessing influenza vaccine uptake among U.S. adults.
The researchers found that from 2020 to 2024, overall flu vaccine uptake decreased, with more than 60 percent of U.S. adults surveyed in May 2020 indicating that they either received the influenza vaccine recently or intended to receive it in the coming months; this compared with 54 percent of U.S. adults surveyed in October 2024. Significant declines were seen among demographic groups usually associated with higher vaccine uptake. People who were older than 35 years (11 percent decrease), male (13 percent), White (7 percent), non-Hispanic (5 percent), or more educated (16 percent) were significantly less likely to receive the influenza vaccine in 2024 versus 2022.
"Changes in attitudes and intentions towards vaccination during and since the COVID-19 pandemic have been associated with several factors, including changes in perceived risk and the rise of vaccine-related mis- and disinformation," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted July 2025
Read this next
COVID-19 Tied to Higher Risk for Inflammatory Diseases of the Airways
THURSDAY, Aug. 28, 2025 -- People who have had COVID-19 have an increased risk for developing certain new-onset type 2 inflammatory diseases of the airways, while receipt of a...
Tdap, MenACWY Coverage Increased in Teens From 2023 to 2024
TUESDAY, Aug. 19, 2025 -- From 2023 to 2024, coverage with one or more doses of the tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine (Tdap) and the...
Two Doses of Zoster Vaccine Reduce Risk for Herpes Zoster Ophthalmicus
TUESDAY, Aug. 19, 2025 -- Two doses of recombinant zoster vaccine (RZV) are associated with a reduced risk for herpes zoster ophthalmicus (HZO), acute myocardial infarction, and...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.